The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis.

IF 7.7 1区 医学 Q1 CRITICAL CARE MEDICINE Critical Care Medicine Pub Date : 2024-07-01 Epub Date: 2024-03-14 DOI:10.1097/CCM.0000000000006244
Katrina M Morgan, Elissa Abou Khalil, Erin V Feeney, Philip C Spinella, Amelia C Lucisano, Barbara A Gaines, Christine M Leeper
{"title":"The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis.","authors":"Katrina M Morgan, Elissa Abou Khalil, Erin V Feeney, Philip C Spinella, Amelia C Lucisano, Barbara A Gaines, Christine M Leeper","doi":"10.1097/CCM.0000000000006244","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess if transfusion with low-titer group O whole blood (LTOWB) is associated with improved early and/or late survival compared with component blood product therapy (CT) in bleeding trauma patients.</p><p><strong>Data sources: </strong>A systematic search of PubMed, CINAHL, and Web of Science was performed from their inception through December 1, 2023. Key terms included injury, hemorrhage, bleeding, blood transfusion, and whole blood.</p><p><strong>Study selection: </strong>All studies comparing outcomes in injured civilian adults and children who received LTOWB versus CT were included.</p><p><strong>Data extraction: </strong>Data including author, publication year, sample size, total blood volumes, and clinical outcomes were extracted from each article and reported following the Meta-analysis Of Observational Studies in Epidemiology guidelines. Main outcomes were 24-hour (early) and combined 28-day, 30-day, and in-hospital (late) mortality rates between recipients of LTOWB versus CT, which were pooled using random-effects models.</p><p><strong>Data synthesis: </strong>Of 1297 studies reviewed, 24 were appropriate for analysis. Total subjects numbered 58,717 of whom 5,164 received LTOWB. Eleven studies included adults-only, seven included both adults and adolescents, and six only included children. The median (interquartile range) age for patients who received LTOWB and CT was 35 years (24-39) and 35.5 years (23-39), respectively. Overall, 14 studies reported early mortality and 22 studies reported late mortality. LTOWB was associated with improved 24-hour survival (risk ratios [RRs] [95% CI] = 1.07 [1.03-1.12]) and late (RR [95% CI] = 1.05 [1.01-1.09]) survival compared with component therapy. There was no evidence of small study bias and all studies were graded as a moderate level of bias.</p><p><strong>Conclusions: </strong>These data suggest hemostatic resuscitation with LTOWB compared with CT improves early and late survival outcomes in bleeding civilian trauma patients. The majority of subjects were injured adults; multicenter randomized controlled studies in injured adults and children are underway to confirm these findings.</p>","PeriodicalId":10765,"journal":{"name":"Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":7.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCM.0000000000006244","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To assess if transfusion with low-titer group O whole blood (LTOWB) is associated with improved early and/or late survival compared with component blood product therapy (CT) in bleeding trauma patients.

Data sources: A systematic search of PubMed, CINAHL, and Web of Science was performed from their inception through December 1, 2023. Key terms included injury, hemorrhage, bleeding, blood transfusion, and whole blood.

Study selection: All studies comparing outcomes in injured civilian adults and children who received LTOWB versus CT were included.

Data extraction: Data including author, publication year, sample size, total blood volumes, and clinical outcomes were extracted from each article and reported following the Meta-analysis Of Observational Studies in Epidemiology guidelines. Main outcomes were 24-hour (early) and combined 28-day, 30-day, and in-hospital (late) mortality rates between recipients of LTOWB versus CT, which were pooled using random-effects models.

Data synthesis: Of 1297 studies reviewed, 24 were appropriate for analysis. Total subjects numbered 58,717 of whom 5,164 received LTOWB. Eleven studies included adults-only, seven included both adults and adolescents, and six only included children. The median (interquartile range) age for patients who received LTOWB and CT was 35 years (24-39) and 35.5 years (23-39), respectively. Overall, 14 studies reported early mortality and 22 studies reported late mortality. LTOWB was associated with improved 24-hour survival (risk ratios [RRs] [95% CI] = 1.07 [1.03-1.12]) and late (RR [95% CI] = 1.05 [1.01-1.09]) survival compared with component therapy. There was no evidence of small study bias and all studies were graded as a moderate level of bias.

Conclusions: These data suggest hemostatic resuscitation with LTOWB compared with CT improves early and late survival outcomes in bleeding civilian trauma patients. The majority of subjects were injured adults; multicenter randomized controlled studies in injured adults and children are underway to confirm these findings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低滴度 O 群全血与成分疗法对平民创伤患者的疗效比较:一项 Meta 分析。
目的:评估与成分血制品疗法(CT)相比,输注低滴度 O 型全血(LTOWB)是否能提高创伤出血患者的早期和/或后期生存率:评估与成分血制品疗法(CT)相比,输注低滴度O型全血(LTOWB)是否能提高创伤出血患者的早期和/或晚期生存率:数据来源:对 PubMed、CINAHL 和 Web of Science 进行了系统检索,检索时间从开始到 2023 年 12 月 1 日。关键词包括受伤、出血、出血、输血和全血:数据提取:数据提取:从每篇文章中提取包括作者、发表年份、样本大小、总血量和临床结果在内的数据,并按照流行病学观察性研究的 Meta 分析指南进行报告。主要结果为LTOWB与CT相比的24小时(早期)死亡率以及28天、30天和住院期间(晚期)的综合死亡率,采用随机效应模型进行汇总:在所审查的 1297 项研究中,有 24 项适合进行分析。受试者总数为58717人,其中5164人接受了LTOWB治疗。11项研究仅包括成人,7项研究包括成人和青少年,6项研究仅包括儿童。接受LTOWB和CT治疗的患者年龄中位数(四分位间距)分别为35岁(24-39岁)和35.5岁(23-39岁)。总体而言,14 项研究报告了早期死亡率,22 项研究报告了晚期死亡率。与组件疗法相比,LTOWB 可提高 24 小时生存率(风险比 [RRs] [95% CI] = 1.07 [1.03-1.12])和晚期生存率(RR [95% CI] = 1.05 [1.01-1.09])。没有证据表明存在小型研究偏倚,所有研究均被评为中度偏倚:这些数据表明,与 CT 相比,使用 LTOWB 进行止血复苏可改善平民创伤出血患者的早期和晚期生存预后。大多数受试者是受伤的成年人;目前正在对受伤的成年人和儿童进行多中心随机对照研究,以证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Critical Care Medicine
Critical Care Medicine 医学-危重病医学
CiteScore
16.30
自引率
5.70%
发文量
728
审稿时长
2 months
期刊介绍: Critical Care Medicine is the premier peer-reviewed, scientific publication in critical care medicine. Directed to those specialists who treat patients in the ICU and CCU, including chest physicians, surgeons, pediatricians, pharmacists/pharmacologists, anesthesiologists, critical care nurses, and other healthcare professionals, Critical Care Medicine covers all aspects of acute and emergency care for the critically ill or injured patient. Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research, and advances in equipment and techniques.
期刊最新文献
Time Controlled Adaptive Ventilation/Airway Pressure Release Ventilation Can be Used Effectively in Patients With or at High Risk of Acute Respiratory Distress Syndrome "Time is the Soul of the World" Pythagoras. Caution-Do Not Attempt This at Home. Airway Pressure Release Ventilation Should Not Routinely Be Used in Patients With or at Risk of Acute Respiratory Distress Syndrome Outside of a Clinical Trial. Resuscitation for Donation After Brain Death: Respecting Autonomy and Maximizing Utility. Cardiopulmonary Resuscitation for Organ Preservation After Death Risks Public Trust and Requires Explicit Consent. Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1